Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Company research

Everfront Biotech Holding Co Ltd

CIK 2001611Updated Sep 24, 2026

No exchange listing on record for this SEC filer. Coverage is drawn from its filings.

Filing activity

SEC EDGAR
Latest filing

F-1/A · Dec 11, 2025

7 filings on record · F-1/A, F-1, DRS/A, DRS.

About the company

Everfront Holding is a holding company incorporated in the British Virgin Islands (“BVI”) that conducts its operations through its 99.96% owned subsidiary, Everfront Biotech Inc. (“Everfront Biotech”), which is incorporated and operates in Taiwan. Everfront Holding holds no other assets and conducts no operations of its own.

F-1 · 2025-01-03 · 0001493152-25-000300

Company description from the cited filing.

Recent filings

  1. F-1/A filing

    F-1/A · 2025-12-11 · 0001493152-25-027247

  2. F-1/A filing

    F-1/A · 2025-06-23 · 0001641172-25-015965

  3. F-1 filing

    F-1 · 2025-01-03 · 0001493152-25-000300

  4. DRS/A filing

    DRS/A · 2024-12-06 · 0001493152-24-048932

  5. DRS/A filing

    DRS/A · 2024-09-27 · 0001493152-24-038612

Show 2 more recent filings
  1. DRS/A filing

    DRS/A · 2024-08-22 · 0001493152-24-033562

  2. DRS filing

    DRS · 2024-06-14 · 0001493152-24-023808

Offerings

Registration 333-284134

F-1 · 2025-01-03 · 0001493152-25-000300

Terms from the governing filing for this registration; not a claim that the offering is open today.

Underwriters: The Benchmark Company, LLC

Filing attachments

ex107.htm · F-1 · 2025-01-03

EX-FILING FEES 20 ex107.htm Exhibit 107 Calculation of Filing Fee Table Form F-1 (Form Type) Everfront Biotech Holding Company Limited Newly Registered Securities and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Share Maximum Fee Rate

F-1 · 2025-01-03 · 0001493152-25-000300

Read attachment ↗
ex99-2.htm · F-1 · 2025-01-03

EX-99.2 17 ex99-2.htm Exhibit 99.2 Audit Committee Charter This Audit Committee Charter (“ Charter ”) has been adopted by the Board of Directors (the “ Board ”) of Everfront Biotech Holding Company Limited (the “ Company ”). The Audit Committee of the Board (the “ Committee ”) shall review and reassess the adequacy of this charter annually and recommend any proposed changes to the Board for approval. Role and Independence; Organization The Committee assists the Board in its oversight of:

F-1 · 2025-01-03 · 0001493152-25-000300

Read attachment ↗